|1.||Fernández-Ruiz, Javier: 4 articles (05/2012 - 05/2003)|
|2.||Beal, M F: 3 articles (06/2008 - 08/2000)|
|3.||Zhang, Zhenzhong: 2 articles (10/2014 - 01/2013)|
|4.||Kumar, Anil: 2 articles (06/2013 - 05/2010)|
|5.||Kalonia, Harikesh: 2 articles (06/2013 - 05/2010)|
|6.||Aguirre, N: 2 articles (04/2013 - 11/2005)|
|7.||Sagredo, Onintza: 2 articles (05/2012 - 08/2009)|
|8.||Hao, Fu-Hua: 2 articles (03/2012 - 02/2011)|
|9.||Upur, Halmurat: 2 articles (04/2011 - 02/2011)|
|10.||Mamtimin, Batur: 2 articles (04/2011 - 02/2011)|
11/01/1992 - "Malonic acid showed a protective action on rats in acute hypoxic hypoxia. "
09/01/1991 - "Endogenic malonic acid is supposed to be of great importance in stimulating tissue resistance to hypoxia."
09/01/1991 - "Malonic acid injection causes an increase in the survival of rats with acute hypoxic hypoxia. "
09/01/1991 - "[Protective effect of malonic acid in hypoxic hypoxia]."
04/01/2013 - "The present study was designed to assess the effects of sildenafil against chemical hypoxia induced by malonate. "
|2.||Brain Injuries (Brain Injury)
04/08/2004 - "Two regions of malonate-induced brain injury were visualized as a hyperintense region with surrounding hypointense regions by apparent diffusion coefficient mapping magnetic resonance imaging. "
09/06/2002 - "Ischemic brain injury induced by injection of 3-micromol malonate into the left striatum of male Sprague-Dawley rats was examined by apparent water diffusion coefficient (ADC) mapping of magnetic resonance imaging. "
08/28/1995 - "Intra-striatal injections of the mitochondrial inhibitor malonate elicit age-dependent neuronal damage in rat brain; injury is more extensive in older animals than in young adults. "
04/08/2004 - "Protection against malonate-induced ischemic brain injury in rat by a cell-permeable peptidic c-Jun N-terminal kinase inhibitor, (L)-HIV-TAT48-57-PP-JBD20, observed by the apparent diffusion coefficient mapping magnetic resonance imaging method."
|3.||Amyotrophic Lateral Sclerosis (Lou Gehrig's Disease)
04/18/2005 - "To establish an in vitro model of amyotrophic lateral sclerosis (ALS) from the organotypic culture of SD rats' lumber spinal cord induced by the mitochondrial inhibitor,malonate sodium. "
03/01/2000 - "The free radical scavenger alpha-phenyl-N-tert-butylnitrone, the AMPA/kainate receptor blocker 6-cyano-7-nitroquinoxaline-2,3-dione, and riluzole, a drug that is currently used for the treatment of amyotrophic lateral sclerosis, were protective against malonate-induced motoneuron death. "
|4.||Colonic Neoplasms (Colon Cancer)
09/01/2009 - "Cp2Mo(malonate) and [Cp2Mo(maltolato)]Cl showed slight improvement in terms of cytotoxic activity as compared with Cp2MoCl2 in the HT-29 colon cancer cell line, whereas for MCF-7 all the molybdenocene species exhibited a proliferative profile. "
09/01/2009 - "The cytotoxic activities of Cp2Mo(malonate) and [Cp2Mo(maltolato)]Cl alone with Cp2MoCl2 were investigated in HT-29 colon cancer and MCF-7 breast cancer cell lines using 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide cell viability assay. "
|5.||Huntington Disease (Huntington's Disease)
08/15/2009 - "Here, we examined this hypothesis in a rat model of Huntington's disease (HD) generated by intrastriatal injection of the mitochondrial complex II inhibitor malonate. "
06/02/2008 - "In the malonate lesion model of Huntington's disease, Dld deficiency did not alter the lesion-induced increase and migration of Dcx-positive cells from the SVZ into the ipsilateral striatum. "
01/01/2007 - "The mitochondrial complex II inhibitor malonate causes striatal damage reminiscent of Huntington's disease and is known to involve oxidative stress in its pathogenesis. "
11/01/2005 - "For instance, in an in vivo model of Huntington's disease, it fails to afford protection after malonate intrastriatal injection. "
08/01/2001 - "Partial resistance to malonate-induced striatal cell death in transgenic mouse models of Huntington's disease is dependent on age and CAG repeat length."
|3.||p38 Mitogen-Activated Protein Kinases
|4.||JNK Mitogen-Activated Protein Kinases
|6.||6-Cyano-7-nitroquinoxaline-2,3-dione (6 Cyano 7 nitroquinoxaline 2,3 dione)
|7.||alpha- Amino- 3- hydroxy- 5- methyl- 4- isoxazolepropionic Acid (AMPA)
|8.||Kainic Acid Receptors (Kainate Receptor)
|10.||Succinate Dehydrogenase (Fumarate Reductase)
|1.||Phototherapy (Light Therapy)